Works matching IS 15747891 AND DT 2021 AND VI 15 AND IP 9
Results: 20
Focus on blood cancers and liquid biopsy research.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2251, doi. 10.1002/1878-0261.13073
- Publication type:
- Article
MicroRNAs in blood act as biomarkers of colorectal cancer and indicate potential therapeutic targets.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2480, doi. 10.1002/1878-0261.13065
- By:
- Publication type:
- Article
Characterization of fragment sizes, copy number aberrations and 4‐mer end motifs in cell‐free DNA of hepatocellular carcinoma for enhanced liquid biopsy‐based cancer detection.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2377, doi. 10.1002/1878-0261.13041
- By:
- Publication type:
- Article
Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2285, doi. 10.1002/1878-0261.13035
- By:
- Publication type:
- Article
NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2363, doi. 10.1002/1878-0261.13033
- By:
- Publication type:
- Article
Circulating exosomal miR‐363‐5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2466, doi. 10.1002/1878-0261.13029
- By:
- Publication type:
- Article
CDX2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibition.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2318, doi. 10.1002/1878-0261.12982
- By:
- Publication type:
- Article
Unveiling mutational dynamics in non‐small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2423, doi. 10.1002/1878-0261.12976
- By:
- Publication type:
- Article
Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2401, doi. 10.1002/1878-0261.12972
- By:
- Publication type:
- Article
FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2300, doi. 10.1002/1878-0261.12961
- By:
- Publication type:
- Article
The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2491, doi. 10.1002/1878-0261.12939
- By:
- Publication type:
- Article
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2453, doi. 10.1002/1878-0261.12933
- By:
- Publication type:
- Article
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2330, doi. 10.1002/1878-0261.12931
- By:
- Publication type:
- Article
Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2273, doi. 10.1002/1878-0261.12921
- By:
- Publication type:
- Article
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2253, doi. 10.1002/1878-0261.12899
- By:
- Publication type:
- Article
Discovery and validation of extracellular vesicle‐associated miRNAs as noninvasive detection biomarkers for early‐stage non‐small‐cell lung cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2439, doi. 10.1002/1878-0261.12889
- By:
- Publication type:
- Article
Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX<sup>®</sup>‐i120 Platform: A prospective study.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2345, doi. 10.1002/1878-0261.12876
- By:
- Publication type:
- Article
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR<sup>+</sup> breast cancer patients undergoing CDK4/6 treatment.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2390, doi. 10.1002/1878-0261.12870
- By:
- Publication type:
- Article
KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2412, doi. 10.1002/1878-0261.12848
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 9, p. 2249, doi. 10.1002/1878-0261.12722
- Publication type:
- Article